Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)

European stocks started the day on May 21 with a slightly weaker note, marking a retreat from their recent impressive performance, with attention now shifting towards the upcoming earnings report from NVIDIA. The Stoxx 600 index dipped by 0.2%, showing a predominantly negative trend across most sectors, while futures for US equities remained relatively unchanged. Options markets in the US indicate significant anticipation for NVIDIA Corporation (NASDAQ:NVDA) earnings report this Wednesday, with traders expecting a notable shift in the chipmaker's shares, reported Reuters.

JPMorgan Chase CEO Jamie Dimon signaled that his retirement might be closer than ever. This news could have a significant impact on the banking industry. Trump Media Enterprises, the media company founded by former President Donald Trump, reported a net loss of $327.6 million in the first quarter of 2024, despite generating only $770,500 in revenue. Home improvement retailer Lowe's Companies reported better-than-expected earnings despite signs that consumers might be cutting back on spending on DIY projects. Bitcoin is currently experiencing a significant price increase, breaking the $71,000 mark for the first time since early April. Ethereum (Ether) is also experiencing a strong rally, jumping over 20% in response to ETF (Exchange-Traded Fund) optimism. This could signal increased institutional interest in the cryptocurrency space.

A scientist in a laboratory, studying a sample under a microscope.

Meanwhile, in Asia, shares took a breather following a week-long streak of gains. Investors remained vigilant regarding commodity prices, especially with the Bloomberg Commodity Spot Index hitting its highest point since January 2023. Notably, gold and copper were trading near their historical peaks, adding to the market's attention.

On another front, oil prices experienced a decline, influenced by various market metrics suggesting a subdued outlook, despite heightened geopolitical tensions ahead of an OPEC+ meeting on supply. Brent crude's prompt spread narrowed to its smallest backwardation since January, indicating a potential shift in market dynamics, while the reduction in bets on crude price increases continued among money managers. Futures trading reflected a period of consolidation, with implied volatility levels nearing lows not seen since 2019.

From Chinese property market side, analysts suggest that China's recent efforts to bolster the property sector will require patience to yield results. Despite these initiatives, S&P maintains its view that the market is still "searching for a bottom." Edward Chan from S&P emphasizes the government's seriousness in stabilizing the property sector but notes that significant stabilization requires improvements in homebuyers' demand and confidence, which have been affected by a nearly three-year market downturn. According to CNBC, recent measures, including lowered down payment minimums and enhanced liquidity for developers, aim to address the challenges. However, analysts like Goldman Sachs' Hui Shan and Nomura's Ting Lu believe more substantial actions are needed, estimating a significant funding requirement to address inventory excess and stabilize prices. While progress is noted, challenges persist, as indicated by declining real estate investment and slower-than-expected retail sales growth. Rebuilding homebuyer confidence is crucial, particularly concerning delivery delays and economic uncertainty. Analysts anticipate further efforts from Beijing, including a national survey to assess funding needs for completing residential projects. Ultimately, restoring confidence in the presale system is seen as essential for a genuine recovery in China's housing markets. As market players navigate these developments, attention remains keenly focused on unfolding events and their potential impact on investment strategies and market sentiment.

On the stock market front, analysts are bearish on stocks such as KALA BIO, Inc. (NASDAQ:KALA) by lowering their price targets. For a comprehensive overview of KALA BIO, Inc. (NASDAQ:KALA) and other stocks affected by such adjustments, see Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks .

KALA BIO, Inc. (NASDAQ:KALA)

Price Reaction after the Price Target Cut: -0.13(-1.95%)

On May 20, H.C. Wainwright revised down the 12-month price target for KALA BIO, Inc. (NASDAQ:KALA) from $21 to $18, despite maintaining a Buy rating on the stock. This adjustment followed the company's first-quarter financial report earlier in the week, which disclosed a net loss of $11.8 million, or $4.20 per share, surpassing the expected loss of $8.8 million. Despite the financial setback, KALA BIO, Inc. (NASDAQ:KALA) management has conveyed that the Phase 2b CHASE trial for KPI-012, designed to address persistent corneal epithelial defect (PCED), is progressing according to plan, with topline results anticipated by the end of 2024. KPI-012, an innovative therapy based on mesenchymal stem cell secretome (MSC-S), integrates various biological factors with the potential to target the multiple causes of PCED.

The absence of FDA-approved treatments covering all underlying causes of PCED underscores the significance of KPI-012, which also holds promise for addressing Limbal Stem Cell Deficiency (LSCD) and other corneal ailments. Additionally, KALA BIO, Inc. (NASDAQ:KALA) is engaged in preclinical research on KPI-014, aimed at inherited retinal degenerative diseases such as retinitis pigmentosa and Stargardt disease. The company's valuation currently stands at $91 million. With an estimated 5.0 million shares outstanding by the close of the first quarter of 2025, the valuation per share amounts to approximately $18. Hence, despite the reduction in the price target, the Buy rating remains intact based on these prospects.

You can visit Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks to see the other stocks that are downgraded.

• If you are looking for an AI stock that is as promising as Microsoft but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

• READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.

Disclosure: None. This article is originally published at Insider Monkey.